State Ledger
Company profile

Greenwich LifeSciences, Inc. CIK 1799788

Ticker
GLSI (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Stafford, TX 77477
Fiscal year end
2025 (FY)
Market Data
Close
$17.83
Change
+$1.17
Change %
6.99%
Volume
5,188

GLSI · trading date Oct 12, 2026 · previous close $16.66 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$19.36M
Total assets
$6.18M
Total liabilities
$5.82M
Stockholders' equity
$353.2K
Cash & equivalents
$6.18M
Operating income
-$19.45M
Operating cash flow
-$9.91M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-06-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
94.3%
Equity / assets
5.7%
CapEx / revenue
—
Operating cash flow / net income
0.51×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$19.36M $6.18M $5.82M $353.2K
2024 — -$17.41M $4.09M $3.19M $908.6K
2023 — -$8.89M $6.99M $294.4K $6.70M
2022 — -$7.83M $13.48M $262.9K $13.21M
2021 — -$4.57M $27.22M $385.2K $26.83M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-11
Financials filed via
Form 10-K
filed 2026-06-01

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Stafford, TX 77477
3992 BLUEBONNET DR, BUILDING 14
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:58 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies